Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neumora Therapeutics, Inc.

1.28
-0.1200-8.57%
Post-market: 1.310.0300+2.34%19:56 EDT
Volume:914.58K
Turnover:1.21M
Market Cap:207.33M
PE:-0.84
High:1.43
Open:1.42
Low:1.27
Close:1.40
Loading ...

Positive Prospects for Neumora Therapeutics: Buy Rating Supported by Leadership Change and Strategic R&D Focus

TIPRANKS
·
14 Feb

Neumora Therapeutics Announces Leadership Changes and Strategy

TIPRANKS
·
14 Feb

Neumora Therapeutics Names Paul Berns as CEO, Michael Milligan as CFO

MT Newswires Live
·
13 Feb

Neumora Therapeutics Announces Leadership Transition

THOMSON REUTERS
·
13 Feb

Neumora Therapeutics Inc - Paul L. Berns to Serve as CEO and Chairman of Neumora

THOMSON REUTERS
·
13 Feb

Neumora Therapeutics Inc - BILL Aurora to Serve as COO and Cdo, Michael Milligan as CFO

THOMSON REUTERS
·
13 Feb

Neumora Therapeutics Announces Leadership Transition

GlobeNewswire
·
13 Feb

Levi & Korsinsky LLP Reminds Shareholders of a Lead Plaintiff Deadline of April 07, 2025 in Neumora Therapeutics, Inc. Lawsuit – NMRA

TIPRANKS
·
08 Feb

3 US Penny Stocks With Market Caps Over $30M To Watch

Simply Wall St.
·
10 Jan

Biotech Stock Roundup: NMRA Plunges on Study Failure, HOTH, VIR Soar on Study Data & More

Zacks
·
10 Jan

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA) and Idexx Laboratories (IDXX)

TIPRANKS
·
06 Jan

Neumora Therapeutics price target lowered to $7 from $22 at BofA

TIPRANKS
·
06 Jan

Neumora shares look oversold after 80% drop, says Mizuho

TipRanks
·
04 Jan

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live
·
04 Jan

Neumora Therapeutics Up Over 16%, on Pace for Largest Percent Increase Since December 2023 -- Data Talk

Dow Jones
·
04 Jan

Neumora Has 2 More Chances With Navacaprant After Readout Miss, Mizuho Says

MT Newswires Live
·
03 Jan